• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

专家共识:老年患者爆发性癌痛管理。德尔菲研究。

Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study.

机构信息

Hospital General Universitario de Valencia, Avenida Tres Cruces, 2, 46014, Valencia, Spain.

Consorcio Hospital Provincial de Castellón, Avenida del Dr. Clarà, 19, 12002 Castellón, Spain.

出版信息

J Geriatr Oncol. 2019 Jul;10(4):643-652. doi: 10.1016/j.jgo.2019.03.012. Epub 2019 Apr 26.

DOI:10.1016/j.jgo.2019.03.012
PMID:31036463
Abstract

OBJECTIVES

We aimed to generate expert-based recommendations on the management of breakthrough cancer pain (BTcP) in older patients with cancer.

MATERIAL AND METHODS

A two-round multidisciplinary Delphi study. Specialists rated their agreement with a set of statements using a nine-point Likert scale (one = totally disagree and nine = totally agree). Statements were classified as appropriate (median ranged from seven to nine), irrelevant (median ranged from four to six) or inappropriate (median ranged from one to three). Consensus was established when at least two thirds of the panel scored within any of the ranges.

RESULTS

A total of 64 specialists from pain units (44.4%), palliative care units (25.4%), medical oncology (19.1%), geriatric medicine (7.9%) and others (3.2%), participated in two consultation rounds. Specialists agreed that effective coordination between the different specialties and levels of care is essential for proper management of BTcP. Most participants (81.3%) supported the assessment of frailty and resolved (96.8%) that frailty status is a better indicator of patient needs than biological age. Participants agreed (75.8%) in the application of the Davies algorithm for diagnosis of BTcP in older patients. A strong consensus was achieved regarding which pharmacological treatment (transmucosal fentanyl) and dosing method (start low and go slow) are the most suitable for the older population. No agreement was reached on how interventionist techniques should be integrated into the therapeutic strategy for BTcP.

CONCLUSIONS

The present Delphi has generated a set of recommendations that will help healthcare professionals in the management of BTcP in older patients.

摘要

目的

我们旨在为癌症老年患者突破性癌痛(BTcP)的管理提供基于专家的建议。

材料和方法

两轮多学科 Delphi 研究。专家使用九点 Likert 量表(1=完全不同意,9=完全同意)对一组陈述的同意程度进行评分。陈述被归类为合适(中位数范围为 7 到 9)、不相关(中位数范围为 4 到 6)或不合适(中位数范围为 1 到 3)。当至少三分之二的小组在任何范围内评分时,即达成共识。

结果

共有来自疼痛科(44.4%)、姑息治疗科(25.4%)、肿瘤内科(19.1%)、老年医学科(7.9%)和其他科室(3.2%)的 64 名专家参加了两轮咨询。专家们一致认为,不同专业和护理水平之间的有效协调对于 BTcP 的妥善管理至关重要。大多数参与者(81.3%)支持评估脆弱性,并明确(96.8%)脆弱状态是患者需求的更好指标,而不是生物年龄。参与者一致认为(75.8%)应在老年患者中应用 Davies 算法诊断 BTcP。在哪些药物治疗(经黏膜芬太尼)和剂量方案(从低剂量开始缓慢增加)最适合老年人群方面达成了强烈共识。对于如何将介入技术纳入 BTcP 的治疗策略,尚未达成共识。

结论

目前的 Delphi 研究产生了一套建议,将有助于医疗保健专业人员管理老年患者的 BTcP。

相似文献

1
Expert consensus on the management of breakthrough cancer pain in older patients. A Delphi study.专家共识:老年患者爆发性癌痛管理。德尔菲研究。
J Geriatr Oncol. 2019 Jul;10(4):643-652. doi: 10.1016/j.jgo.2019.03.012. Epub 2019 Apr 26.
2
Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.突破性癌痛个体化治疗:哪些因素影响药物选择?一项终末期癌症患者的观察性、前瞻性和横断面研究。
Postgrad Med J. 2018 Oct;94(1116):566-570. doi: 10.1136/postgradmedj-2018-135659. Epub 2018 Oct 13.
3
Diagnosis and management of breakthrough cancer pain: Have all the questions been resolved? A Delphi-based consensus assessment (DOIRON).突破性癌痛的诊断与管理:所有问题都解决了吗?基于德尔菲法的共识评估(DOIRON)
Clin Transl Oncol. 2016 Sep;18(9):945-54. doi: 10.1007/s12094-015-1468-7. Epub 2015 Dec 22.
4
Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study.影响阿片类药物治疗爆发性癌痛的因素:IOPS-MS 研究的二次分析。
Eur J Pain. 2019 Apr;23(4):719-726. doi: 10.1002/ejp.1339. Epub 2018 Dec 28.
5
Breakthrough cancer pain (BTcP) management: a review of international and national guidelines.突破性癌痛(BTcP)管理:国际和国内指南综述
BMJ Support Palliat Care. 2018 Sep;8(3):241-249. doi: 10.1136/bmjspcare-2017-001467. Epub 2018 Jun 6.
6
Current management of breakthrough cancer pain according to physicians from pain units in Spain.西班牙疼痛科医师对爆发性癌痛的管理现状。
Clin Transl Oncol. 2019 Sep;21(9):1168-1176. doi: 10.1007/s12094-019-02044-8. Epub 2019 Feb 19.
7
Breakthrough Cancer Pain: A Systematic Review of Pharmacologic Management
.突破性癌痛:药物治疗的系统评价
Clin J Oncol Nurs. 2017 Jun 1;21(3 Suppl):71-80. doi: 10.1188/17.CJON.S3.71-80.
8
Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS.临床实践中用于缓解突破性癌症疼痛的芬太尼颊片剂:非干预性前瞻性研究 ErkentNIS 的结果。
Support Care Cancer. 2018 Feb;26(2):491-497. doi: 10.1007/s00520-017-3853-y. Epub 2017 Aug 28.
9
Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study.癌痛的定义、评估、治疗及监测中的共识与争议:德尔菲研究结果
Clin Transl Oncol. 2016 Nov;18(11):1088-1097. doi: 10.1007/s12094-016-1490-4.
10
Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription.西班牙突破性癌症疼痛治疗:医生对当前阿片类药物使用和处方的看法。
Curr Med Res Opin. 2020 Aug;36(8):1383-1391. doi: 10.1080/03007995.2020.1775073. Epub 2020 Jun 11.

引用本文的文献

1
US expert Delphi consensus on the prevention and management of stomatitis in patients treated with datopotamab deruxtecan.美国专家关于达泊西汀治疗患者口腔炎预防与管理的德尔菲共识。 (注:原文中的“datopotamab deruxtecan”常见翻译为“达泊西汀”,但从医学角度看这个词不太准确,可能原文有误,推测正确的药名是“datopotamab deruxtecan”更合适,但按照指令要求,按提供原文翻译。)
Support Care Cancer. 2025 Aug 5;33(9):756. doi: 10.1007/s00520-025-09805-y.
2
Pharmacological Pain Treatment in Older Persons.老年人的药物性疼痛治疗
Drugs Aging. 2024 Dec;41(12):959-976. doi: 10.1007/s40266-024-01151-8. Epub 2024 Oct 27.
3
A rapid systematic review of breakthrough pain definitions and descriptions.
突破性疼痛定义与描述的快速系统评价
Br J Pain. 2024 Jun;18(3):215-226. doi: 10.1177/20494637231208093. Epub 2023 Dec 25.
4
Management of pain in patients with bone metastases.骨转移患者的疼痛管理
Front Oncol. 2023 Mar 16;13:1156618. doi: 10.3389/fonc.2023.1156618. eCollection 2023.
5
Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily Practice.用于管理癌症突发疼痛的快速起效阿片类药物:日常实践中的考量
Front Pain Res (Lausanne). 2022 May 26;3:893530. doi: 10.3389/fpain.2022.893530. eCollection 2022.
6
Current management of cancer pain in Italy: Expert opinion paper.意大利癌症疼痛的当前管理:专家意见文件。
Open Med (Wars). 2021 Dec 6;17(1):34-45. doi: 10.1515/med-2021-0393. eCollection 2022.
7
The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain.美国疼痛与神经科学学会(ASPN)癌症相关疼痛介入管理的最佳实践与指南。
J Pain Res. 2021 Jul 16;14:2139-2164. doi: 10.2147/JPR.S315585. eCollection 2021.
8
Impact of individualized management of breakthrough cancer pain on quality of life in advanced cancer patients: CAVIDIOPAL study.突破性癌痛个体化管理对晚期癌症患者生活质量的影响:CAVIDIOPAL 研究。
Support Care Cancer. 2021 Aug;29(8):4799-4807. doi: 10.1007/s00520-021-06006-1. Epub 2021 Feb 3.
9
A protocol for a systematic review and meta-analysis to identify measures of breakthrough pain and evaluate their psychometric properties.用于系统评价和荟萃分析的方案,旨在识别突破性疼痛的测量指标并评估其心理测量学特性。
BMJ Open. 2020 Mar 29;10(3):e035541. doi: 10.1136/bmjopen-2019-035541.
10
Assessing the capacity of Malawi's district and central hospitals to manage traumatic diaphyseal femoral fractures in adults.评估马拉维地区和中心医院治疗成人骨干外伤性股骨干骨折的能力。
PLoS One. 2019 Nov 20;14(11):e0225254. doi: 10.1371/journal.pone.0225254. eCollection 2019.